Off the wire
Chinese shares open higher Wednesday  • S. Africa's JSE closes firmer as rand slides  • Auto parts giant Aptiv moving headquarters from Britain to Ireland  • UN chief to appoint special advisor to probe resumption of Cyprus peace talks  • Backstop not part of EU's tactics in Brexit talks: Barnier  • Portugal buys 272 mln 1, 2 cent coins from Ireland  • Ireland unemployment rate drops to decade low  • 71 pct of student nurses consider leaving Ireland after graduation: survey  • Irish manufacturing sector picks up growth in April  • Chinese shares open higher Wednesday  
You are here:  

Vietnam's pharmaceutical import drops in January-April

Xinhua,May 03, 2018 Adjust font size:

HANOI, May 3 (Xinhua) -- Vietnam spent 801 million U.S. dollars importing evidence-based medicines from January to April, seeing a year-on-year decline of 2.9 percent, according to the country's General Statistics Office on Thursday.

Vietnam's medicine import turnovers were over 2.8 billion U.S. dollars last year, mainly coming from France, India, Germany, South Korea, the United States, Britain, Italy, Switzerland, Belgium and Thailand.

According to global research firm BMI Research, Vietnams pharmaceutical market in 2017 grew some 10 percent against 2016 to 5.2 billion U.S. dollars, and it would continue to grow at a double-digit rate in the next five years.

On average, one Vietnamese person's annual spending on pharmaceutical products rose to 37.97 U.S. dollars in 2015 from 22.25 U.S. dollars in 2010 and 9.85 U.S. dollars in 2005, said a local ratings company named Vietnam Report.

The spending will surge to 85 U.S. dollars by 2020 and 163 U.S. dollars by 2025, the Vietnamese company predicted. Enditem